KR20220152296A - Gpr52 조절제 화합물 - Google Patents
Gpr52 조절제 화합물 Download PDFInfo
- Publication number
- KR20220152296A KR20220152296A KR1020227035100A KR20227035100A KR20220152296A KR 20220152296 A KR20220152296 A KR 20220152296A KR 1020227035100 A KR1020227035100 A KR 1020227035100A KR 20227035100 A KR20227035100 A KR 20227035100A KR 20220152296 A KR20220152296 A KR 20220152296A
- Authority
- KR
- South Korea
- Prior art keywords
- fluoro
- trifluoromethyl
- pyridin
- benzyl
- pyrazole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/16—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Amplifiers (AREA)
- Optical Modulation, Optical Deflection, Nonlinear Optics, Optical Demodulation, Optical Logic Elements (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2003668.7A GB202003668D0 (en) | 2020-03-13 | 2020-03-13 | GPR52 Modulator compounds |
| GB2003668.7 | 2020-03-13 | ||
| PCT/GB2021/050638 WO2021181122A1 (en) | 2020-03-13 | 2021-03-15 | Gpr52 modulator compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20220152296A true KR20220152296A (ko) | 2022-11-15 |
Family
ID=70453676
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020227035100A Pending KR20220152296A (ko) | 2020-03-13 | 2021-03-15 | Gpr52 조절제 화합물 |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20240254101A1 (https=) |
| EP (1) | EP4117784B1 (https=) |
| JP (1) | JP7492597B2 (https=) |
| KR (1) | KR20220152296A (https=) |
| CN (1) | CN115515681B (https=) |
| AU (1) | AU2021235257A1 (https=) |
| BR (1) | BR112022018287A2 (https=) |
| CA (1) | CA3175429A1 (https=) |
| DK (1) | DK4117784T3 (https=) |
| ES (1) | ES2992600T3 (https=) |
| FI (1) | FI4117784T3 (https=) |
| GB (1) | GB202003668D0 (https=) |
| HR (1) | HRP20241375T1 (https=) |
| HU (1) | HUE068758T2 (https=) |
| IL (1) | IL296413B2 (https=) |
| LT (1) | LT4117784T (https=) |
| MX (1) | MX2022011333A (https=) |
| PL (1) | PL4117784T3 (https=) |
| PT (1) | PT4117784T (https=) |
| RS (1) | RS66063B1 (https=) |
| SI (1) | SI4117784T1 (https=) |
| SM (1) | SMT202400402T1 (https=) |
| WO (1) | WO2021181122A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202206413A (zh) | 2020-04-22 | 2022-02-16 | 美商紐羅克里生物科學有限公司 | Gpr52調節劑及其使用方法 |
| EP4330232A1 (en) * | 2021-04-26 | 2024-03-06 | Neurocrine Biosciences, Inc. | Gpr52 modulators and methods of use |
| GB202113186D0 (en) | 2021-09-15 | 2021-10-27 | Heptares Therapeutics Ltd | GPR52 Modulator compounds |
| WO2024091541A1 (en) * | 2022-10-26 | 2024-05-02 | Neurocrine Biosciences, Inc. | Compounds and compositions as gpr52 modulators |
| JP2026508053A (ja) * | 2022-10-26 | 2026-03-10 | ニューロクライン バイオサイエンシーズ，インコーポレイテッド | Ｇｐｒ５２モジュレーターとしての化合物および組成物 |
| WO2024091542A1 (en) * | 2022-10-26 | 2024-05-02 | Neurocrine Biosciences, Inc. | Compounds and compositions as gpr52 modulators |
| WO2025252061A1 (zh) * | 2024-06-04 | 2025-12-11 | 海思科医药集团股份有限公司 | 一种gpr52激动剂及其在医药上的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005037797A1 (en) * | 2003-10-21 | 2005-04-28 | Pharmacia Corporation | Substituted pyrazole urea compounds for the treatment of inflammation |
| WO2009107391A1 (ja) | 2008-02-27 | 2009-09-03 | 武田薬品工業株式会社 | ６員芳香環含有化合物 |
| WO2011078360A1 (ja) | 2009-12-24 | 2011-06-30 | 武田薬品工業株式会社 | アミド化合物 |
| EP2530078A1 (en) | 2010-01-27 | 2012-12-05 | Takeda Pharmaceutical Company Limited | Thiazole derivative |
| KR20180004193A (ko) * | 2015-04-29 | 2018-01-10 | 아레나 파마슈티칼스, 인크. | Gpr52와 관련된 장애의 치료 또는 예방을 위한 gpr52 조절제로서 1-헤테로아릴-인돌린-4-카르복스아미드 |
| JP7394747B2 (ja) * | 2017-09-13 | 2023-12-08 | ノバルティス アーゲー | ジフェニル誘導体及びその使用 |
-
2020
- 2020-03-13 GB GBGB2003668.7A patent/GB202003668D0/en not_active Ceased
-
2021
- 2021-03-15 HR HRP20241375TT patent/HRP20241375T1/hr unknown
- 2021-03-15 ES ES21713103T patent/ES2992600T3/es active Active
- 2021-03-15 EP EP21713103.6A patent/EP4117784B1/en active Active
- 2021-03-15 SI SI202130212T patent/SI4117784T1/sl unknown
- 2021-03-15 US US17/909,792 patent/US20240254101A1/en active Pending
- 2021-03-15 RS RS20241089A patent/RS66063B1/sr unknown
- 2021-03-15 AU AU2021235257A patent/AU2021235257A1/en active Pending
- 2021-03-15 IL IL296413A patent/IL296413B2/en unknown
- 2021-03-15 WO PCT/GB2021/050638 patent/WO2021181122A1/en not_active Ceased
- 2021-03-15 LT LTEPPCT/GB2021/050638T patent/LT4117784T/lt unknown
- 2021-03-15 DK DK21713103.6T patent/DK4117784T3/da active
- 2021-03-15 PT PT217131036T patent/PT4117784T/pt unknown
- 2021-03-15 CA CA3175429A patent/CA3175429A1/en active Pending
- 2021-03-15 SM SM20240402T patent/SMT202400402T1/it unknown
- 2021-03-15 MX MX2022011333A patent/MX2022011333A/es unknown
- 2021-03-15 PL PL21713103.6T patent/PL4117784T3/pl unknown
- 2021-03-15 KR KR1020227035100A patent/KR20220152296A/ko active Pending
- 2021-03-15 HU HUE21713103A patent/HUE068758T2/hu unknown
- 2021-03-15 BR BR112022018287A patent/BR112022018287A2/pt unknown
- 2021-03-15 FI FIEP21713103.6T patent/FI4117784T3/fi active
- 2021-03-15 CN CN202180033813.9A patent/CN115515681B/zh active Active
- 2021-03-15 JP JP2022555137A patent/JP7492597B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP7492597B2 (ja) | 2024-05-29 |
| EP4117784A1 (en) | 2023-01-18 |
| SMT202400402T1 (it) | 2024-11-15 |
| GB202003668D0 (en) | 2020-04-29 |
| IL296413A (en) | 2022-11-01 |
| ES2992600T3 (en) | 2024-12-16 |
| CA3175429A1 (en) | 2021-09-16 |
| AU2021235257A1 (en) | 2022-10-06 |
| SI4117784T1 (sl) | 2025-03-31 |
| LT4117784T (lt) | 2024-10-25 |
| EP4117784B1 (en) | 2024-08-28 |
| DK4117784T3 (da) | 2024-10-14 |
| CN115515681A (zh) | 2022-12-23 |
| CN115515681B (zh) | 2024-09-03 |
| JP2023519666A (ja) | 2023-05-12 |
| RS66063B1 (sr) | 2024-11-29 |
| IL296413B1 (en) | 2025-11-01 |
| FI4117784T3 (fi) | 2024-10-10 |
| US20240254101A1 (en) | 2024-08-01 |
| MX2022011333A (es) | 2022-12-08 |
| HUE068758T2 (hu) | 2025-01-28 |
| HRP20241375T1 (hr) | 2024-12-20 |
| PL4117784T3 (pl) | 2025-01-13 |
| BR112022018287A2 (pt) | 2022-11-22 |
| WO2021181122A1 (en) | 2021-09-16 |
| PT4117784T (pt) | 2024-10-07 |
| IL296413B2 (en) | 2026-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20220152296A (ko) | Gpr52 조절제 화합물 | |
| KR102151288B1 (ko) | [오르토 바이 (헤테로 )아릴]-[2-(메타 바이 (헤테로 )아릴)-피롤리딘-1-일]-메타논 유도체인 오렉신 수용체 안타고니스트 | |
| ES2460915T3 (es) | Piridinas fusionadas con heteroarilo disustituido | |
| KR101873083B1 (ko) | 오렉신 길항제로서 유용한 신규 피라졸 및 이미다졸 유도체 | |
| CA2670404A1 (en) | Heteromonocyclic compound and use thereof | |
| JP2012507512A (ja) | アミロイドβのモジュレーター | |
| CA3120037A1 (en) | Heteroaromatic compounds as vanin inhibitors | |
| KR20150130413A (ko) | 오렉신 수용체 길항제로서의 아제티딘 아미드 유도체 | |
| WO2017073743A1 (ja) | 三環性化合物 | |
| EP4401833B1 (en) | Gpr52 modulator compounds | |
| JP7761635B2 (ja) | Ｇｐｒ５２モジュレーター化合物 | |
| RU2844473C1 (ru) | Соединения модуляторы gpr52 | |
| HK40078521B (en) | Gpr52 modulator compounds | |
| HK40078521A (en) | Gpr52 modulator compounds | |
| KR101318689B1 (ko) | 칸나비노이드 ｃｂ1 수용체 길항제로서 황 함유 피라졸-헤테로사이클 유도체 | |
| HK40107480B (en) | Gpr52 modulator compounds | |
| HK40107480A (en) | Gpr52 modulator compounds | |
| WO2026033382A1 (en) | Heterocyclic glp-1r modulators | |
| WO2026078674A1 (en) | Heterocyclic derivatives as glucose-dependent insulinotropic polypeptide receptor antagonists and uses thereof | |
| KR20140062096A (ko) | Parp 억제제 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
St.27 status event code: A-0-1-A10-A15-nap-PA0105 |
|
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-3-3-R10-R18-oth-X000 |
|
| R17-X000 | Change to representative recorded |
St.27 status event code: A-3-3-R10-R17-oth-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| PN2301 | Change of applicant |
St.27 status event code: A-3-3-R10-R13-asn-PN2301 St.27 status event code: A-3-3-R10-R11-asn-PN2301 |
|
| D21 | Rejection of application intended |
Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D21-EXM-PE0902 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |